Probing structural selectivity of synthetic heparin binding to stabilin protein receptors

Journal of Biological Chemistry

Volumn 287, Issue 25, 2012, Pages 20774-20783

  Pempe, Elizabeth H ^b   Xu, Yongmei ^b   Gopalakrishnan, Sandhya ^a   Liu, Jian ^b   Harris, Edward N ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b University of North Carolina   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CIRCULATION; CLEARANCE RATES; HEPARAN SULFATES; HEPARIN BINDING; LOW-MOLECULAR WEIGHT HEPARINS; PHYSICAL PARAMETERS; PROTEIN RECEPTORS; STRUCTURAL SELECTIVITY;

CARDIOVASCULAR SYSTEM; DIALYSIS; DISEASES; MOLECULAR BIOLOGY; OLIGOMERS;

POLYSACCHARIDES;

GLUCOSAMINE SULFATE; HEPARAN SULFATE; HEPARIN; OLIGOMER; RECEPTOR PROTEIN; STABILIN 1 RECEPTOR; STABILIN 2 RECEPTOR; STABILIN RECEPTOR; SULFUR 35; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DESIGN; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG RETENTION; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SULFATION; ENDOCYTOSIS; IN VITRO STUDY; INTERNALIZATION; ISOTOPE LABELING; LIVER PARENCHYMA; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRUCTURE ANALYSIS;

ANIMALS; ANTICOAGULANTS; CARBOHYDRATE CONFORMATION; CELL ADHESION MOLECULES, NEURONAL; CELL LINE; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HEPARIN; HUMANS; LIVER; MICE; MICE, INBRED BALB C; RECEPTORS, LYMPHOCYTE HOMING;

EID: 84862285980     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.320069     Document Type: Article

References (42)

1. Jacobs, L. G. (2003) Prophylactic anticoagulation for venous thromboembolic disease in geriatric patients. J. Am. Geriatr. Soc. 51, 1472-1478
2. Verhaeghe, R. (1998) The use of low molecular weight heparins in cardiovascular disease. Acta Cardiol. 53, 15-21
3. Dinwoodey, D. L., and Ansell, J. E. (2006) Heparins, low molecular weight heparins, and pentasaccharides. Clin. Geriatr. Med. 22, 1-15
4. Oie, C. I., Olsen, R., Smedsrød, B., and Hansen, J. B. (2008) Liver sinusoidal endothelial cells are the principal site for elimination of unfractionated heparin from the circulation. Am. J. Physiol. Gastrointest. Liver Physiol. 294, G520-G528 (Pubitemid 351253343)
5. Harris, E. N., Weigel, J. A., and Weigel, P. H. (2008) The human hyaluronan receptor for endocytosis (HARE/Stabilin-2) is a systemic clearance receptor for heparin. J. Biol. Chem. 283, 17341-17350
6. Hansen, B., Longati, P., Elvevold, K., Nedredal, G. I., Schledzewski, K., Olsen, R., Falkowski, M., Kzhyshkowska, J., Carlsson, F., Johansson, S., Smedsrød, B., Goerdt, S., Johansson, S., and McCourt, P. (2005) Stabilin-1 and stabilin-2 are both directed into the early endocytic pathway in hepatic sinusoidal endothelium via interactions with clathrin/AP-2, independent of ligand binding. Exp. Cell Res. 303, 160-173 (Pubitemid 39575152)
7. Harris, E. N., Kyosseva, S. V., Weigel, J. A., and Weigel, P. H. (2007) Expression, processing, and glycosaminoglycan binding activity of the recombinant human 315-kDa hyaluronic acid receptor for endocytosis (HARE). J. Biol. Chem. 282, 2785-2797 (Pubitemid 47084328)
8. Harris, E. N., Weigel, J. A., and Weigel, P. H. (2004) Endocytic function, glycosaminoglycan specificity, and antibody sensitivity of the recombinant human 190-kDa hyaluronan receptor for endocytosis (HARE). J. Biol. Chem. 279, 36201-36209 (Pubitemid 39128955)
9. Harris, E. N., and Weigel, P. H. (2008) The ligand-binding profile of HARE: hyaluronan and chondroitin sulfates A, C, and D bind to overlapping sites distinct from the sites for heparin, acetylated low density lipoprotein, dermatan sulfate, and CS-E. Glycobiology 18, 638-648
10. Goerdt, S., Bhardwaj, R., and Sorg, C. (1993) Inducible expression of MS-1 high molecular weight protein by endothelial cells of continuous origin and by dendritic cells/macrophages in vivo and in vitro. Am. J. Pathol. 142, 1409-1422 (Pubitemid 24058128)
11. Kzhyshkowska, J., Gratchev, A., and Goerdt, S. (2006) Stabilin-1, a homeostatic scavenger receptor with multiple functions. J. Cell Mol. Med. 10, 635-649 (Pubitemid 44874274)
12. Kzhyshkowska, J., Workman, G., Cardó-Vila, M., Arap, W., Pasqualini, R., Gratchev, A., Krusell, L., Goerdt, S., and Sage, E. H. (2006) Novel function of alternatively activated macrophages: stabilin-1-mediated clearance of SPARC. J. Immunol. 176, 5825-5832
13. Kzhyshkowska, J., Gratchev, A., Schmuttermaier, C., Brundiers, H., Krusell, L., Mamidi, S., Zhang, J., Workman, G., Sage, E. H., Anderle, C., Sedlmayr, P., and Goerdt, S. (2008) Alternatively activated macrophages regulate extracellular levels of the hormone placental lactogen via receptor-mediated uptake and transcytosis. J. Immunol. 180, 3028-3037
14. Kzhyshkowska, J., Gratchev, A., Brundiers, H., Mamidi, S., Krusell, L., and Goerdt, S. (2005) Phosphatidylinositide 3-kinase activity is required for stabilin-1-mediated endosomal transport of acLDL. Immunobiology 210, 161-173 (Pubitemid 41025157)
15. Schledzewski, K., Géraud, C., Arnold, B., Wang, S., Gröne, H. J., Kempf, T., Wollert, K. C., Straub, B. K., Schirmacher, P., Demory, A., Schönhaber, H., Gratchev, A., Dietz, L., Thierse, H. J., Kzhyshkowska, J., and Goerdt, S. (2011) Deficiency of liver sinusoidal scavenger receptors stabilin-1 and -2 in mice causes glomerulofibrotic nephropathy via impaired hepatic clearance of noxious blood factors. J. Clin. Invest. 121, 703-714
16. Park, S. Y., Jung, M. Y., Kim, H. J., Lee, S. J., Kim, S. Y., Lee, B. H., Kwon, T. H., Park, R. W., and Kim, I. S. (2008) Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor. Cell Death Differ. 15, 192-201
17. Lee, S. J., Park, S. Y., Jung, M. Y., Bae, S. M., and Kim, I. S. (2011) Mechanism for phosphatidylserine-dependent erythrophagocytosis in mouse liver. Blood 117, 5215-5223
18. Park, S. Y., Jung, M. Y., Lee, S. J., Kang, K. B., Gratchev, A., Riabov, V., Kzhyshkowska, J., and Kim, I. S. (2009) Stabilin-1 mediates phosphatidylserine-dependent clearance of cell corpses in alternatively activated macrophages. J. Cell Sci. 122, 3365-3373
19. Tamura, Y., Adachi, H., Osuga, J., Ohashi, K., Yahagi, N., Sekiya, M., Okazaki, H., Tomita, S., Iizuka, Y., Shimano, H., Nagai, R., Kimura, S., Tsujimoto, M., and Ishibashi, S. (2003) FEEL-1 and FEEL-2 are endocytic receptors for advanced glycation end products. J. Biol. Chem. 278, 12613-12617 (Pubitemid 36800020)
20. Peterson, S., Frick, A., and Liu, J. (2009) Design of biologically active heparan sulfate and heparin using an enzyme-based approach. Nat. Prod. Rep. 26, 610-627
21. Chen, J., Avci, F. Y., Muñoz, E. M., McDowell, L. M., Chen, M., Pedersen, L. C., Zhang, L., Linhardt, R. J., and Liu, J. (2005) Enzymatic redesigning of biologically active heparan sulfate. J. Biol. Chem. 280, 42817-42825 (Pubitemid 43049243)
22. Chen, J., Jones, C. L., and Liu, J. (2007) Using an enzymatic combinatorial approach to identify anticoagulant heparan sulfate structures. Chem. Biol. 14, 986-993 (Pubitemid 47404901)
23. Liu, R., Xu, Y., Chen, M., Weïwer, M., Zhou, X., Bridges, A. S., DeAngelis, P. L., Zhang, Q., Linhardt, R. J., and Liu, J. (2010) Chemoenzymatic design of heparan sulfate oligosaccharides. J. Biol. Chem. 285, 34240-34249
24. Xu, Y., Masuko, S., Takieddin, M., Xu, H., Liu, R., Jing, J., Mousa, S. A., Linhardt, R. J., and Liu, J. (2011) Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins. Science 334, 498-501
25. Xia, G., Chen, J., Tiwari, V., Ju, W., Li, J. P., Malmstrom, A., Shukla, D., and Liu, J. (2002) Heparan sulfate 3-O-sulfotransferase isoform 5 generates both an antithrombin-binding site and an entry receptor for herpes simplex virus, type 1. J. Biol. Chem. 277, 37912-37919
26. Wary, K. K., Thakker, G. D., Humtsoe, J. O., and Yang, J. (2003) Analysis of VEGF-responsive genes involved in the activation of endothelial cells. Mol. Cancer 2, 25
27. Zhou, X., Chandarajoti, K., Pham, T. Q., Liu, R., and Liu, J. (2011) Expression of heparan sulfate sulfotransferases in Kluyveromyces lactis and preparation of 3′-phosphoadenosine-5′-phosphosulfate. Glycobiology 21, 771-780
28. Liu, J., and Pedersen, L. C. (2007) Anticoagulant heparan sulfate: structural specificity and biosynthesis. Appl. Microbiol. Biotechnol. 74, 263-272 (Pubitemid 46204499)
29. Rosenberg, R. D., Shworak, N. W., Liu, J., Schwartz, J. J., and Zhang, L. (1997) Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge, but how is synthesis regulated? J. Clin. Invest. 99, 2062-2070 (Pubitemid 27203760)
30. Olson, S. T., and Chuang, Y. J. (2002) Heparin activates antithrombin anticoagulant function by generating new interaction sites (exosites) for blood clotting proteinases. Trends Cardiovasc. Med. 12, 331-338 (Pubitemid 36092123)
31. Richard, B., Swanson, R., and Olson, S. T. (2009) The signature 3-O-sulfo group of the anticoagulant heparin sequence is critical for heparin binding to antithrombin but is not required for allosteric activation. J. Biol. Chem. 284, 27054-27064
32. Liu, J., Shworak, N. W., Fritze, L. M., Edelberg, J. M., and Rosenberg, R. D. (1996) Purification of heparan sulfate D-glucosaminyl 3-O- sulfotransferase. J. Biol. Chem. 271, 27072-27082 (Pubitemid 26359127)
33. Hirsh, J., O'Donnell, M., and Eikelboom, J. W. (2007) Beyond unfractionated heparin and warfarin: current and future advances. Circulation 116, 552-560 (Pubitemid 47450264)
34. Tobu, M., Iqbal, O., Hoppensteadt, D., Neville, B., Messmore, H. L., and Fareed, J. (2004) Anti-Xa and anti-IIa drugs alter international normalized ratio measurements: potential problems in the monitoring of oral anticoagulants. Clin. Appl. Thromb. Hemost. 10, 301-309 (Pubitemid 39391290)
35. Weitz, J. I. (2010) Potential of new anticoagulants in patients with cancer. Thromb. Res. 125, Suppl. 2, S30-S35
36. Atha, D. H., Lormeau, J. C., Petitou, M., Rosenberg, R. D., and Choay, J. (1985) Contribution of monosaccharide residues in heparin binding to antithrombin III. Biochemistry 24, 6723-6729 (Pubitemid 16207156)
37. Moon, A. F., Xu, Y., Woody, S. M., Krahn, J. M., Linhardt, R. J., Liu, J., and Pedersen, L. C. (2012) Dissecting the substrate recognition of 3-O-sulfotransferase for the biosynthesis of anticoagulant heparin. Proc. Natl. Acad. Sci. U.S.A. 109, 5265-5270
38. Falkowski, M., Schledzewski, K., Hansen, B., and Goerdt, S. (2003) Expression of stabilin-2, a novel fasciclin-like hyaluronan receptor protein, in murine sinusoidal endothelia, in avascular tissues, and at solid/liquid interfaces. Histochem. Cell Biol. 120, 361-369 (Pubitemid 38005355)
39. Penc, S. F., Pomahac, B., Winkler, T., Dorschner, R. A., Eriksson, E., Herndon, M., and Gallo, R. L. (1998) Dermatan sulfate released after injury is a potent promoter of fibroblast growth factor-2 function. J. Biol. Chem. 273, 28116-28121 (Pubitemid 28496107)
40. Taylor, K. R., Rudisill, J. A., and Gallo, R. L. (2005) Structural and sequence motifs in dermatan sulfate for promoting fibroblast growth factor-2 (FGF-2) and FGF-7 activity. J. Biol. Chem. 280, 5300-5306 (Pubitemid 40280003)
41. Zhou, B., Weigel, J. A., Fauss, L., and Weigel, P. H. (2000) Identification of the hyaluronan receptor for endocytosis (HARE). J. Biol. Chem. 275, 37733-37741 (Pubitemid 32004888)
42. Prevo, R., Banerji, S., Ni, J., and Jackson, D. G. (2004) Rapid plasma membrane-endosomal trafficking of the lymph node sinus and high endothelial venule scavenger receptor/homing receptor stabilin-1 (FEEL-1/CLEVER-1). J. Biol. Chem. 279, 52580-52592 (Pubitemid 39656635)